Select for export Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/npr2.70152 PubMed 42379141 Copy citation Copy BibTeX Neuropsychopharmacology Reports 2026-08-31 Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko Crossref Published psilocybinpsilocin DepressionAnxietyReceptor Pharmacology Animal Study More
Select for export Phase 1 trial suggests benefit of psilocybin in OCD treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31474 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2026-07-31 Authors unavailable Crossref Published psilocybin OCDClinical TrialAdverse Events Clinical Trial More
Select for export Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64898/2026.07.16.733837 Copy citation Copy BibTeX bioRxiv 2026-07-20 Jacobs, D. S.; Pacheco, A. T.; Olson, R.; Langdon, A. J.; Moghaddam, B. New this week bioRxiv PREPRINT (not peer reviewed) psilocybin General Other More
Select for export PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2026-07-20 Johns Hopkins University New this week ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingPharmacologyMechanism of Action Clinical Trial More
Select for export Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)] Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2026-07-20 University of California, San Diego New this week ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAddictionBrain Imaging Other More
Select for export Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64898/2026.07.16.738983 Copy citation Copy BibTeX bioRxiv 2026-07-19 Savalia, N.; Shao, L.-X.; Knox, C. A.; Gilbert, A. D.; Jiang, Q.; Kwan New this week bioRxiv PREPRINT (not peer reviewed) psilocybin NeuroplasticityPharmacologyMechanism of Action Animal Study More
Select for export Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpubh.2026.1767215 Copy citation Copy BibTeX Frontiers in Public Health 2026-07-19 Tsang Vivian WL, Kryskow Pamela, Watler Crosbie, Allard Pearl, Dames Shannon New this week Crossref Published psilocybin End-of-Life DistressResilienceObservational Study Observational Study More
Select for export The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2026-07-19 Yale University New this week ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionMicrodosingRandomized Controlled Trial Randomized Controlled Trial More
Select for export A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64898/2026.07.16.26358273 Copy citation Copy BibTeX medRxiv 2026-07-18 Levy-Cooperman, N.; Sellers, E.; Glue, P.; Szeto, I.; Brown, D.; Jarecki-Smith New this week medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin AnxietyEnd-of-Life DistressPharmacology Clinical Trial More
Select for export Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psyche.2026.100029 Copy citation Copy BibTeX Psychedelics 2026-07-17 Sergio Pérez Rosal, Sonya C. Faber New this week OpenAlex Published psilocybin Observational StudySafetyAdverse Events Observational Study More
Select for export Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-026-02501-3 PubMed 42471435 Copy citation Copy BibTeX Neuropsychopharmacology 2026-07-17 Gattuso JJ, Kamal A, Payet JM, Havaux K, Hendey J, Bezcioglu B New this week Europe PMC Published psilocybin AnxietyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5281/zenodo.21406174 Copy citation Copy BibTeX Zenodo (CERN European Organization for Nuclear Research) 2026-07-16 Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś New this week OpenAlex Published psilocybin DepressionNeuroplasticityMechanism of Action Clinical Trial More
Select for export A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2026-07-16 Diamond Therapeutics Inc. New this week ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Publication bias in randomized trials of psilocybin for depression: a Robust Bayesian Meta-Analysis Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2026-07-16 Authors unavailable New this week PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPharmacologyRandomized Controlled Trial Randomized Controlled Trial More
Select for export Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2026-07-16 Johns Hopkins University New this week ClinicalTrials.gov CLINICAL TRIAL psilocybin AddictionPharmacologyClinical Trial Randomized Controlled Trial More
Select for export The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2026-07-16 Sharmin Ghaznavi New this week ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionBrain ImagingAging Other More
Select for export Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.12775/jehs.2026.94.73071 Copy citation Copy BibTeX Journal of Education Health and Sport 2026-07-15 Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech New this week OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Integrated 5-HT2A-TrkB and G protein signaling in serotonergic psychedelic responses. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-026-03746-6 PubMed 42463904 Copy citation Copy BibTeX Unknown journal 2026-07-15 Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Hidalgo Jiménez J New this week Europe PMC Published psilocin NeuroplasticityPharmacologyMechanism of Action In Vitro Study More
Select for export Uncovering the spatiotemporal structure of neural avalanches through optimal transport and dynamic time warping Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64898/2026.07.10.737743 Copy citation Copy BibTeX bioRxiv 2026-07-15 Novicky, F.; Jajcay, N.; Hlinka, J. New this week bioRxiv PREPRINT (not peer reviewed) psilocybin Brain Imaging Other More
Select for export Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811261464988 PubMed 42460632 Copy citation Copy BibTeX Journal of Psychopharmacology 2026-07-15 Dougherty RF, Modlin NL, McGowan NM, Staples P, Williams E, Clarke P New this week Europe PMC Published psilocybin PTSDConsciousnessClinical Trial Clinical Trial More
